Thrilled to share our new study from the @BordenLacy Lab in collaboration with @AstraZenecaUS, "The monoclonal antibody AZD5148 confers broad protection against TcdB-diverse Clostridioides difficile strains in mice” now out in PLoS Pathogens!
doi.org/10.1371/journal.ppat…
The Peritore Lab officially opens its doors in 2026!
I am seeking an organized, motivated technician to join our team focused on host-pathogen interaction research. For details on current research, check out: peritorelab.com
Job listing: osu.wd1.myworkdayjobs.com/OS…
19/20 AZD5148 is currently in Phase I clinical trials (NCT06469151), and we are hopeful that this monoclonal antibody will help C. difficile patients in the future.